Travere Therapeutics to Present at Upcoming Investor Conferences
Rhea-AI Summary
Travere Therapeutics (NASDAQ: TVTX) has announced its participation in two upcoming investor conferences in August 2024. The company will present at the 2024 Wedbush PacGrow Healthcare Conference on Tuesday, August 13, at 2:30 p.m. ET, and the Canaccord Genuity 44th Annual Growth Conference on Wednesday, August 14, at 12:30 p.m. ET.
A live webcast of the Canaccord Genuity conference presentation will be available on Travere's website investor page, with a replay accessible for up to 30 days after the event. This announcement highlights Travere's commitment to engaging with investors and sharing company updates through these important industry events.
Positive
- None.
Negative
- None.
News Market Reaction – TVTX
In the trading session that priced this news, TVTX declined 5.39%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present in the following upcoming investor conferences in August:
2024 Wedbush PacGrow Healthcare Conference
Tuesday, August 13, 2024, at 2:30 p.m. ET
Canaccord Genuity 44th Annual Growth Conference
Wednesday, August 14, 2024, at 12:30 p.m. ET
A live webcast of the Canaccord Genuity 44th Annual Growth Conference presentation will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations, and a replay will be available for up to 30 days following the event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
Contact:
| Investors: 888-969-7879 IR@travere.com | Media: 888-969-7879 mediarelations@travere.com |
